Pacira Pharmaceuticals, Inc. (PCRX) - Financial and Strategic SWOT Analysis Review

  • ID: 2300622
  • SWOT Analysis
  • 45 pages
  • GlobalData
  • Pacira Pharmaceuticals
1 of 5

FEATURED COMPANIES

  • Akorn, Inc.
  • DURECT Corporation
  • MORE
Pacira Pharmaceuticals, Inc. (PCRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pacira Pharmaceuticals, Inc. (Pacira) is a specialty pharmaceutical company. It focuses on the discovery, development, manufacture and commercialization of novel pharmaceutical products. It develops products based on its proprietary DepoFoam drug delivery technology. The company’s products are used by hospitals and ambulatory surgery centers. Pacira’s lead product candidate is Exparel, a liposome injection of bupivacaine, an amide-type local anesthetic is indicated for infiltration into the surgical site to produce postsurgical analgesia for up to 72 hours. The company’s subsidiaries include Pacira Pharmaceuticals International, Inc., (the US); and Pacira Ltd., (the UK). Pacira is headquartered in Parsippany, New Jersey, the US.

Pacira Pharmaceuticals, Inc. Key Recent Developments

Oct 27, 2015: Pacira Pharmaceuticals Reports Third Quarter 2015 Financial Results
Oct 20, 2015: Pacira Pharmaceuticals Announces the Promotion of James S. Scibetta to President
Aug 19, 2015: Pacira Pharmaceuticals Appoints James B. Jones, MD, PharmD, as Senior Vice President and Chief Medical Officer
Jul 30, 2015: Pacira Pharmaceuticals Reports Second Quarter 2015 Financial Results
Jul 14, 2015: Pacira Pharmaceuticals Appoints Scott Braunstein, MD, to Oversee Strategy and Corporate Development

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Akorn, Inc.
  • DURECT Corporation
  • MORE
List of Tables

List of Figures

Section 1 - About the Company

Pacira Pharmaceuticals, Inc. - Key Facts

Pacira Pharmaceuticals, Inc. - Key Employees

Pacira Pharmaceuticals, Inc. - Key Employee Biographies

Pacira Pharmaceuticals, Inc. - Major Products and Services

Pacira Pharmaceuticals, Inc. - Pharmaceutical Pipeline Products Data

Pacira Pharmaceuticals, Inc., Pipeline Products by Therapy Area

Pacira Pharmaceuticals, Inc., Pipeline Products by Development Phase

Pacira Pharmaceuticals, Inc. - History

Pacira Pharmaceuticals, Inc. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Pacira Pharmaceuticals, Inc. - Business Description

Pacira Pharmaceuticals, Inc. - Corporate Strategy

Pacira Pharmaceuticals, Inc. - SWOT Analysis

SWOT Analysis - Overview

Pacira Pharmaceuticals, Inc. - Strengths

Strength - Lead Product - Exparel

Strength - Research and Development Activities

Strength - Strategic Partnerships and Agreements

Pacira Pharmaceuticals, Inc. - Weaknesses

Weakness - Declining Performance of DepoCyte

Pacira Pharmaceuticals, Inc. - Opportunities

Opportunity - Market Potential: Pain

Opportunity - Pipeline Products

Opportunity - Changing Demographics

Pacira Pharmaceuticals, Inc. - Threats

Threat - Stringent Government Regulations

Threat - Dependence on Third Parties

Threat - Competitive Environment

Pacira Pharmaceuticals, Inc. - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Pacira Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Pacira Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Pacira Pharmaceuticals, Inc., Recent Deals Summary

Section 5 – Company’s Recent Developments

Oct 27, 2015: Pacira Pharmaceuticals Reports Third Quarter 2015 Financial Results

Oct 20, 2015: Pacira Pharmaceuticals Announces the Promotion of James S. Scibetta to President

Aug 19, 2015: Pacira Pharmaceuticals Appoints James B. Jones, MD, PharmD, as Senior Vice President and Chief Medical Officer

Jul 30, 2015: Pacira Pharmaceuticals Reports Second Quarter 2015 Financial Results

Jul 14, 2015: Pacira Pharmaceuticals Appoints Scott Braunstein, MD, to Oversee Strategy and Corporate Development

Apr 30, 2015: Pacira Pharmaceuticals Reports First Quarter EXPAREL Revenues of $56.0 Million and First Quarter 2015 Financial Results

Feb 24, 2015: Pacira Pharmaceuticals Reports 2014 Financial Results

Jan 08, 2015: Pacira Pharmaceuticals Reports Estimated Fourth Quarter Total Revenue of $61.8 Million and Estimated Full-Year Total Revenue of $197.7 Million

Section 6 – Appendix

Methodology

Ratio Definitions

About us

Contact Us

Disclaimer

List of Tables

Pacira Pharmaceuticals, Inc., Key Facts

Pacira Pharmaceuticals, Inc., Key Employees

Pacira Pharmaceuticals, Inc., Key Employee Biographies

Pacira Pharmaceuticals, Inc., Major Products and Services

Pacira Pharmaceuticals, Inc., Number of Pipeline Products by Therapy Area

Pacira Pharmaceuticals, Inc., Number of Pipeline Products by Development Stage

Pacira Pharmaceuticals, Inc., Pipeline Products By Therapy Area and Development Phase

Pacira Pharmaceuticals, Inc., History

Pacira Pharmaceuticals, Inc., Other Locations

Pacira Pharmaceuticals, Inc., Subsidiaries

Pacira Pharmaceuticals, Inc., Key Competitors

Pacira Pharmaceuticals, Inc., Ratios based on current share price

Pacira Pharmaceuticals, Inc., Annual Ratios

Pacira Pharmaceuticals, Inc., Interim Ratios

Pacira Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Pacira Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016

Pacira Pharmaceuticals, Inc., Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

Pacira Pharmaceuticals, Inc., Pipeline Products by Therapy Area

Pacira Pharmaceuticals, Inc., Pipeline Products by Development Phase

Pacira Pharmaceuticals, Inc., Performance Chart (2011 - 2015)

Pacira Pharmaceuticals, Inc., Ratio Charts

Pacira Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016

Pacira Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
Akorn, Inc.
AcelRx Pharmaceuticals, Inc.
Napp Pharmaceuticals Limited
Jazz Pharmaceuticals, Inc.
Scilex Pharmaceuticals, Inc.
DURECT Corporation
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll